Clinical Study of Tolterodine Tartrate in the Treatment of Overactive Bladder

January 2013 in “ Journal of Chengdu Medical College ”

LI Zhi-qian

New to Finasteride? There is a guide in the encyclopedia. Read the guide →

Studysummary In this study, Tolterodine Tartrate significantly improved symptoms of overactive bladder and showed fewer adverse reactions compared to the control group treatment. Our plain-language summary of this paper — not a Tressless recommendation.

The study investigated the effectiveness and safety of Tolterodine Tartrate for treating overactive bladder (OAB) in 60 patients, divided into an experimental group receiving Tolterodine Tartrate and a control group receiving Finasteride and Tan solo sustained-release capsules. Results showed that the experimental group experienced significant reductions in urination frequency, urgency, nocturia, and urge incontinence, along with increased voided volume per urination. The Overactive Bladder Symptom Score (OABSS) and adverse reactions were also lower in the experimental group compared to the control group. The study concluded that Tolterodine Tartrate was an effective treatment for OAB.

View this study on en.cnki.com.cn →

Discuss this study in the Community →

Similar Research

5 / 1000+ results

research Comparison of combination therapy with tamsulosin and dutasteride or finasteride in patients with benign prostatic hyperplasia: a randomized clinical trial

1 citations , September 2024 in “African Journal of Urology”

This study found that dutasteride improved maximum urinary flow rate more effectively than finasteride when used in combination therapy with tamsulosin for treating benign prostatic hyperplasia over six months.

research Tamsulosin versus finasteride: effect on bother and urinary flow

1 citations , January 2002 in “European Urology Supplements”

Tamsulosin works faster, but both drugs have similar effects after 6 months.

A Double-Blind, Randomized, Placebo-Controlled Pilot Study to Investigate the Effects of Finasteride Combined with a Biodegradable Self-Reinforced Poly L-Lactic Acid Spiral Stent in Patients with Urinary Retention Caused by Bladder Outlet Obstruction

research A double-blind, randomized, placebo-controlled pilot study to investigate the effects of finasteride combined with a biodegradable self-reinforced poly l-lactic acid spiral stent in patients with urinary retention caused by bladder outlet obstruction from

30 citations , July 2001 in “BJUI”

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

research Review: Dutasteride, fesoterodine, and finasteride are beneficial for lower urinary tract symptoms in older patients

October 2015 in “Annals of Internal Medicine”

Dutasteride, fesoterodine, and finasteride help older patients with urinary issues.

research Safety and efficacy of advanced and targeted acid α-glucosidase (AT-GAA) (ATB200/AT2221) in ERT-switch nonambulatory patients with Pompe disease: preliminary results from the ATB200-02 trial

3 citations , February 2019 in “Molecular genetics and metabolism”

This study found that coadministration of tadalafil and finasteride improved lower urinary tract symptoms and erectile function in men with benign prostatic hyperplasia better than finasteride alone over 26 weeks.